search
Back to results

Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants

Primary Purpose

Premature Infants, Parent-Child Relations

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
H-HOPE Intervention
Sponsored by
Medical College of Wisconsin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Premature Infants focused on measuring Premature Infants, NICU, Parental Stress, Healthcare Costs

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

There are two cohorts of infants and parents: the Pre-H-HOPE Comparison Cohort and H-HOPE Cohort. H-HOPE is a family intervention, so parent(s) and infants are recruited together and must meet both parent and infant eligibility criteria. Infant and parent eligibility criteria are the same for both cohorts (Pre-H-HOPE and H-HOPE). Additionally, there are criteria for hospital personnel.

Inclusion criteria for the infant:

  • born between 23-35 weeks gestational age (GA)
  • have reached 31-32 weeks post menstrual age (PMA)
  • clinically stable
  • male or female
  • could be receiving oxygen or intravenous therapy
  • could have been previously intubated for mechanical ventilation
  • assessed as ready to begin social interaction Infants of multiple births will be eligible to participate but data from only one randomly selected infant will be used in analysis of Aim 2.

Inclusion criteria for the parent (up to 2 per infant can be in the study:

  • mother, father, other family member, or surrogate parent regardless of age, race/ethnicity, gender, or sexual orientation, or biological relationship to the infant
  • intends to act in the role of parent
  • 18 years of age or older
  • English or Spanish speaking

Inclusion criteria for hospital personnel:

Hospital Administrator - staff member with an administrative role outside of the NICU leadership who is knowledgeable about the activities of the NICU NICU Manager - Nurse or physician with an administrative role in the NICU (e.g. medical director or nurse manager) H-HOPE Team member - staff member who is part of the H-HOPE Team NICU Staff Nurse - registered nurse who provides direct patient care and works a minimum of 50% in the NICU Exclusion Criteria We will not be limiting any participants based on sex/gender, or ethnic/racial identity. Differences due to race and gender will be accounted for during data analysis. We will be limiting enrollment to English or Spanish speaking parents due to the limited availability of valid measures for data collection in languages other than English and Spanish. However, we anticipate that we will still be able to recruit an ethnically diverse group of parents because of the ethnic composition of the parents at the sites and our prior experience.

Exclusion criteria for the infant:

  • major brain injuries (e.g. cystic PVL)
  • current sepsis
  • intubated for mechanical ventilation at time of enrollment
  • surgical necrotizing enterocolitis
  • Ward of the State

Exclusion criteria for the parent:

  • positive drug screen for illegal substances
  • planning to surrender custody of the infant or legal custody remove
  • primary parent does not have legal guardianship of the infant
  • Mental health diagnosis such as Psychosis, Bipolar Disease Exclusion Criteria Hospital Personnel
  • None

Exclusion Criteria for NICU Staff Nurses:

  • less than 50% effort.
  • does not provide direct patient care

Sites / Locations

  • University of ChicagoRecruiting
  • Advocate Aurora Health
  • Duke Univesity
  • Children's Hospital of Wisconsin

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Pre H-HOPE Cohort

H-HOPE Cohort

Arm Description

The Pre-H-HOPE Comparison Cohort will not receive the H-HOPE intervention, and represents the prior standard (non-HOPE).

The H-HOPE Cohort will receive the H-HOPE intervention.

Outcomes

Primary Outcome Measures

Aim 1 Outcome Measure: Implementation Success (Percent Change in Sustainability throughout implementation)
Change in % of instances of H-HOPE being offered
Aim 1 Outcome Measure: Implementation Success (Change in Reach throughout implementation)
% of eligible parent-infant units receiving H-HOPE
Aim 1 Outcome Measure: Implementation Success (Degree of Implementation)
In-Hospital: Infant: Mean number of ATVV interventions received per eligible day (Range 0-2) Transition to home: Parents: # received participatory guidance sessions (2 pre-discharge and 2 screen time visits at 2-3 days and 7-15 days post-discharge; Range: 0-3) Infant: Mean number of ATVV interventions received by per eligible day since discharge (Range 0-2; provided and reported by parent)
Aim 2 Outcome Measure: Effectiveness-(Change in Infant Head Circumference)
Infant Primary: Infant Head Circumference, measured in centimeters.
Aim 2 Outcome Measure: Effectiveness (Change in Infant Weight)
Infant Primary: Weight, measured in kilograms
Aim 2 Outcome Measure: Effectiveness (Change in Infant Length)
Infant Primary: Length, measured in centimeters
Aim 2 Outcome Measure: Effectiveness (Change in number of Acute Care Visits)
Number of acute care visits (clinic or emergency department visit or re-hospitalization)

Secondary Outcome Measures

Aim 2 Outcome Measure: Cost
Mean hospitalization cost/day (direct costs) from entry into H-HOPE through discharge, adjusted by adding the cost per H-HOPE infant to implement H-HOPE (training, coordinating, time to deliver H-HOPE and to arrange screen time visits)
Aim 3 Outcome Measure: CFIR influences (Number of facilitators and barriers to implementation)
Aim 3 uses mixed methods analyses to integrate data collected for this aim regarding influences (facilitators or barriers) in each of the 5 CFIR domains with data from Aim 1 (implementation success) and Aim 2 (effectiveness for the primary infant outcomes).

Full Information

First Posted
August 19, 2020
Last Updated
March 13, 2023
Sponsor
Medical College of Wisconsin
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Duke University, University of Chicago, Advocate Health Care, Children's Hospital and Health System Foundation, Wisconsin
search

1. Study Identification

Unique Protocol Identification Number
NCT04555590
Brief Title
Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants
Official Title
Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 16, 2020 (Actual)
Primary Completion Date
December 1, 2024 (Anticipated)
Study Completion Date
April 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical College of Wisconsin
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Duke University, University of Chicago, Advocate Health Care, Children's Hospital and Health System Foundation, Wisconsin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Early developmentally-based behavioral intervention has well-established positive effects and is recommended as the standard of care to support early brain maturation, health, and development. However, few neonatal intensive care units (NICUs) provide this early intervention. H-HOPE (Hospital to Home: Optimizing the Preterm Infant's Environment) has established efficacy, and has a standardized protocol, making it ready for widespread implementation. The infant-directed component of H-HOPE provides Auditory (voice), Tactile (moderate touch massage), Visual (eye to eye), and Vestibular (rocking) stimulation starting when infants are ready for social interaction. The parent-directed component of H-HOPE includes participatory guidance and support to help parents engage with infants in the NICU and the transition to home. In this NIH-funded research, H-HOPE improved growth, developmental maturity and mother-infant interaction, and reduced initial hospitalization costs and acute care visits through 6-weeks corrected age. This research tests whether H-HOPE can be implemented and sustained in five diverse NICUs, using a Type 3 Hybrid design to evaluate both implementation processes and effectiveness. The specific aims are to: 1) Identify the degree of implementation success; 2) Evaluate the effectiveness of H-HOPE for infants, hospital costs from H-HOPE enrollment until discharge, and parents, compared to a pre-implementation comparison cohort; and 3) Determine influences (facilitators and barriers) associated with implementation success and H-HOPE effectiveness, guided by the Consolidated Framework for Implementation Research (CFIR). An incomplete stepped-wedge design guides staggered roll-out for five clinical sites. Each NICU completes the CFIR implementation steps (Planning and Engaging, Executing, and Reflecting and Evaluating), followed by 6 months of Sustaining. For Aim 1, degree of implementation success is determined every two months as Sustainability (still offering H-HOPE), Reach (% of eligible parent/infant dyads receiving H-HOPE) and Degree of Implementation (mean H-HOPE services received per parent-infant unit) (primary implementation outcomes). For Aim 2, effectiveness is analyzed using generalized linear mixed models for infant, cost, and parent outcomes (primary outcomes: infant growth at discharge and acute care visits from discharge to 6-weeks corrected age). Propensity score analysis is used to make the pre- and post-implementation comparable. For Aim 3, a mixed methods analyses is used to identify influences from H-HOPE records and interviews that are associated with implementation success and effectiveness at each site and across sites. This is the first time implementation in a NICU is guided by the evidence-based CFIR framework, and results will make a major contribution to implementation science. This study will produce an evidence-based implementation strategy and Toolkit to disseminate nationwide. Widespread H-HOPE implementation will make a significant change in clinical practice and improve preterm infant health and health care costs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Infants, Parent-Child Relations
Keywords
Premature Infants, NICU, Parental Stress, Healthcare Costs

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is an implementation study of the H-HOPE Intervention. The team uses a Stepped-Wedge Design for Implementation.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pre H-HOPE Cohort
Arm Type
No Intervention
Arm Description
The Pre-H-HOPE Comparison Cohort will not receive the H-HOPE intervention, and represents the prior standard (non-HOPE).
Arm Title
H-HOPE Cohort
Arm Type
Experimental
Arm Description
The H-HOPE Cohort will receive the H-HOPE intervention.
Intervention Type
Behavioral
Intervention Name(s)
H-HOPE Intervention
Intervention Description
The H-HOPE intervention (Hospital to Home: Optimizing the Preterm Infant's Environment) to promote early infant development and parental engagement. H-HOPE includes ATVV, which provides Auditory (voice), Tactile (moderate touch massage), Visual (eye to eye), and Vestibular (rocking) stimulation with a parent-directed component which provides participatory guidance and social support to engage with their infants.
Primary Outcome Measure Information:
Title
Aim 1 Outcome Measure: Implementation Success (Percent Change in Sustainability throughout implementation)
Description
Change in % of instances of H-HOPE being offered
Time Frame
Every 2 months from Executing through 6 months after supported implementation ends
Title
Aim 1 Outcome Measure: Implementation Success (Change in Reach throughout implementation)
Description
% of eligible parent-infant units receiving H-HOPE
Time Frame
Every 2 months from Executing through 6 months after supported implementation ends
Title
Aim 1 Outcome Measure: Implementation Success (Degree of Implementation)
Description
In-Hospital: Infant: Mean number of ATVV interventions received per eligible day (Range 0-2) Transition to home: Parents: # received participatory guidance sessions (2 pre-discharge and 2 screen time visits at 2-3 days and 7-15 days post-discharge; Range: 0-3) Infant: Mean number of ATVV interventions received by per eligible day since discharge (Range 0-2; provided and reported by parent)
Time Frame
Every 2 months from Executing through 6 months after supported implementation ends
Title
Aim 2 Outcome Measure: Effectiveness-(Change in Infant Head Circumference)
Description
Infant Primary: Infant Head Circumference, measured in centimeters.
Time Frame
From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Title
Aim 2 Outcome Measure: Effectiveness (Change in Infant Weight)
Description
Infant Primary: Weight, measured in kilograms
Time Frame
From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Title
Aim 2 Outcome Measure: Effectiveness (Change in Infant Length)
Description
Infant Primary: Length, measured in centimeters
Time Frame
From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Title
Aim 2 Outcome Measure: Effectiveness (Change in number of Acute Care Visits)
Description
Number of acute care visits (clinic or emergency department visit or re-hospitalization)
Time Frame
At 6 weeks post discharge
Secondary Outcome Measure Information:
Title
Aim 2 Outcome Measure: Cost
Description
Mean hospitalization cost/day (direct costs) from entry into H-HOPE through discharge, adjusted by adding the cost per H-HOPE infant to implement H-HOPE (training, coordinating, time to deliver H-HOPE and to arrange screen time visits)
Time Frame
From infant enrollment through infant discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Title
Aim 3 Outcome Measure: CFIR influences (Number of facilitators and barriers to implementation)
Description
Aim 3 uses mixed methods analyses to integrate data collected for this aim regarding influences (facilitators or barriers) in each of the 5 CFIR domains with data from Aim 1 (implementation success) and Aim 2 (effectiveness for the primary infant outcomes).
Time Frame
From the completion of the first site's Sustaining Phase through Final Analysis of all site data, estimated to be 39 months.
Other Pre-specified Outcome Measures:
Title
Aim 2 Exploratory Outcome Measure: # Parent NICU visits/days of hospitalization
Description
# Parent NICU visits/days of hospitalization (each parent)
Time Frame
At discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Title
Aim 2 Exploratory Outcome Measure: Parental Stress (Anxiety)
Description
PROMIS SF v1.0 - Anxiety7a
Time Frame
At discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant) and 6 weeks corrected Age
Title
Aim 2 Exploratory Outcome Measure: Parental Stress (Depression)
Description
PROMIS SF v1.0 - Depression 8b
Time Frame
At discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant) and 6 weeks corrected Age
Title
Aim 2 Exploratory Outcome Measure: Parental Stress (Child Health Worry Scale)
Description
Child Health Worry Scale. The scale values are 1=not worried; 2=somewhat worried; 3=moderately worried; 4=very worried; 5=extremely worried
Time Frame
At discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant) and 6 weeks corrected Age
Title
Aim 2 Exploratory Outcome Measure: Confidence in Care
Description
(KPCS) Karitane Parenting Confidence Scale. The following choices are available to select for each of the scale's questions: No, hardly ever (0 points) , No, not very often (1 point), Yes, some of the time (2 points), Yes, most of the time (3 points). The points are added up and a total score is calculated. Parents with a total score of 39 or less may be experiencing low levels of parenting confidence.
Time Frame
At discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant) and 6 weeks corrected Age

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
There are two cohorts of infants and parents: the Pre-H-HOPE Comparison Cohort and H-HOPE Cohort. H-HOPE is a family intervention, so parent(s) and infants are recruited together and must meet both parent and infant eligibility criteria. Infant and parent eligibility criteria are the same for both cohorts (Pre-H-HOPE and H-HOPE). Additionally, there are criteria for hospital personnel. Inclusion criteria for the infant: born between 23-35 weeks gestational age (GA) have reached 31-32 weeks post menstrual age (PMA) clinically stable male or female could be receiving oxygen or intravenous therapy could have been previously intubated for mechanical ventilation assessed as ready to begin social interaction Infants of multiple births will be eligible to participate but data from only one randomly selected infant will be used in analysis of Aim 2. Inclusion criteria for the parent (up to 2 per infant can be in the study: mother, father, other family member, or surrogate parent regardless of age, race/ethnicity, gender, or sexual orientation, or biological relationship to the infant intends to act in the role of parent 18 years of age or older English or Spanish speaking Inclusion criteria for hospital personnel: Hospital Administrator - staff member with an administrative role outside of the NICU leadership who is knowledgeable about the activities of the NICU NICU Manager - Nurse or physician with an administrative role in the NICU (e.g. medical director or nurse manager) H-HOPE Team member - staff member who is part of the H-HOPE Team NICU Staff Nurse - registered nurse who provides direct patient care and works a minimum of 50% in the NICU Exclusion Criteria We will not be limiting any participants based on sex/gender, or ethnic/racial identity. Differences due to race and gender will be accounted for during data analysis. We will be limiting enrollment to English or Spanish speaking parents due to the limited availability of valid measures for data collection in languages other than English and Spanish. However, we anticipate that we will still be able to recruit an ethnically diverse group of parents because of the ethnic composition of the parents at the sites and our prior experience. Exclusion criteria for the infant: major brain injuries (e.g. cystic PVL) current sepsis intubated for mechanical ventilation at time of enrollment surgical necrotizing enterocolitis Ward of the State Exclusion criteria for the parent: positive drug screen for illegal substances planning to surrender custody of the infant or legal custody remove primary parent does not have legal guardianship of the infant Mental health diagnosis such as Psychosis, Bipolar Disease Exclusion Criteria Hospital Personnel None Exclusion Criteria for NICU Staff Nurses: less than 50% effort. does not provide direct patient care
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rosemary White-Traut, PhD,RN,FAAN
Phone
414-337-0261
Email
RWhite-Traut@chw.org
First Name & Middle Initial & Last Name or Official Title & Degree
Claire Walsh, BA
Phone
414-337-0266
Email
CWalsh@chw.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rosemary White-Traut, PhD,RN,FAAN
Organizational Affiliation
Department of Nursing Research and Evidence-Based Practice Children's Wisconsin
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60637
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bree Andrews, MD, MPH
Facility Name
Advocate Aurora Health
City
Park Ridge
State/Province
Illinois
ZIP/Postal Code
60068
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Preetha Prazad, MD
Facility Name
Duke Univesity
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27708
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Debra H Brandon, PhD,RN,CNS,FAAN
Facility Name
Children's Hospital of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53201
Country
United States
Individual Site Status
Not yet recruiting

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33761902
Citation
White-Traut R, Brandon D, Kavanaugh K, Gralton K, Pan W, Myers ER, Andrews B, Msall M, Norr KF. Protocol for implementation of an evidence based parentally administered intervention for preterm infants. BMC Pediatr. 2021 Mar 24;21(1):142. doi: 10.1186/s12887-021-02596-1.
Results Reference
derived
Links:
URL
https://www.ncbi.nlm.nih.gov/sites/myncbi/1zuy2pmUXmu5a/bibliography/48083153/public/?sort=date&direction=ascending
Description
Complete List of Published Work in MyBibliography for Rosemary White-Traut

Learn more about this trial

Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants

We'll reach out to this number within 24 hrs